Synapse - Mark Kris

Search Within

Mark Kris

Results (73)

Clinical characteristics and outcomes of patients with EGFR-mutant lung cancer with acquired BRAF alterations

Meeting Abstract

Sui, J.; Yang, S. R.; Bowman, A. S.; Vankayala, P.; Falcon, C.; Somwar, R.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Ladanyi, M.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Predictors of benefit to radiation for oligoprogressive disease in EGFR -mutant metastatic non-small cell lung cancer patients treated with osimertinib

Meeting Abstract

Chen, M. F.; Ma, J.; Kris, M. G.; Gomez, D. R.; Yu, H. A.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Clinical outcomes and genomic landscape of patients (pts) with EGFR-mutant lung cancer (EGFR+ LC) with central nervous system (CNS) metastases (mets)

Meeting Abstract

Sui, J. S. Y.; Wilcox, J.; Tischfield, S.; Choudhury, N. J.; Riely, G. J.; Kris, M. G.; Boire, A. A.; Yu, H. A.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Tumor-agnostic genomic and clinical analysis of solid tumors with BRAF fusions

Meeting Abstract

Chen, M. F.; Yang, S. R.; Tao, J.; Desilets, A.; Rosen, E.; Gong, Y.; Mullaney, K. A.; Kris, M. G.; Arcila, M. E.; Donoghue, M.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer

Meeting Abstract

Mukherjee, S.; Schroeder, A.; Chatterjee, S.; Cadley, J.; Falcon, C. J.; Mehine, M.; Bandlamudi, C.; Chatterjee, A.; Ladanyi, M.; Solit, D. B.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study

Journal Article

Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
Journal for ImmunoTherapy of Cancer (2023)

Fulltext@MSK | Save

Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer

Conference Paper

Lengel, H. B.; Zheng, J.; Tan, K. S.; Liu, C. C.; Park, B. J.; Rocco, G.; Adusumilli, P. S.; Molena, D.; Yu, H. A.; Riely, G. J.; more...
Mosby Elsevier (2023)

Fulltext@MSK | Save

Brief report: Combination of osimertinib and dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas

Journal Article

Elkrief, A.; Makhnin, A.; Moses, K. A.; Ahn, L. S.; Preeshagul, I. R.; Iqbal, A. N.; Hayes, S. A.; Plodkowski, A. J.; Paik, P. K.; Ladanyi, M.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers

Journal Article

Choudhury, N. J.; Marra, A.; Sui, J. S. Y.; Flynn, J.; Yang, S. R.; Falcon, C. J.; Selenica, P.; Schoenfeld, A. J.; Rekhtman, N.; Gomez, D.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Outcomes of single-agent PD-(L)-1 versus combination with chemotherapy in patients with PD-L1-high (≥ 50%) lung cancer

Meeting Abstract

Elkrief, A.; Machado Alessi, J. V.; Ricciuti, B.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Chaft, J. E.; Rudin, C. M.; Riely, G. J.; Kris, M. G.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save